131 related articles for article (PubMed ID: 30794970)
1. Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma.
Wang J; Che F; Zhang J; Zhang M; Xiao S; Liu Y; Zhou L; Su Q; You C; Lu Y; Heng X
World Neurosurg; 2019 May; 125():e1217-e1225. PubMed ID: 30794970
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
3. Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma.
Xiao Y; Zhang L; Song Z; Guo C; Zhu J; Li Z; Zhu S
Med Sci Monit; 2016 Mar; 22():855-62. PubMed ID: 26978735
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
5. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
Wang LQ; Sun W; Wang Y; Li D; Hu AM
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
[TBL] [Abstract][Full Text] [Related]
7. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
Chen J; Yang L; Wang X
Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553
[TBL] [Abstract][Full Text] [Related]
8. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA-376 family as diagnostic and prognostic markers in human gliomas.
Huang Q; Wang C; Hou Z; Wang G; Lv J; Wang H; Yang J; Zhang Z; Zhang H
Cancer Biomark; 2017; 19(2):137-144. PubMed ID: 28211798
[TBL] [Abstract][Full Text] [Related]
10. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.
Cheng W; Ren X; Zhang C; Han S; Wu A
J Neurooncol; 2017 Apr; 132(2):207-218. PubMed ID: 28091987
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
[TBL] [Abstract][Full Text] [Related]
13. A novel serum microRNA-based identification and classification biomarker of human glioma.
Xing W; Zeng C
Tumour Biol; 2017 May; 39(5):1010428317705339. PubMed ID: 28475008
[TBL] [Abstract][Full Text] [Related]
14. microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells.
Yuan J; Zheng Z; Zheng Y; Lu X; Xu L; Lin L
Int J Neurosci; 2016; 126(2):145-53. PubMed ID: 25562367
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.
Wang J; Zhang X; Wang L; Dong Z; Du L; Yang Y; Guo Y; Wang C
J Surg Oncol; 2015 Jun; 111(8):992-9. PubMed ID: 25975233
[TBL] [Abstract][Full Text] [Related]
16. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.
Li X; Zheng J; Chen L; Diao H; Liu Y
Mol Neurobiol; 2016 Jan; 53(1):577-583. PubMed ID: 25502291
[TBL] [Abstract][Full Text] [Related]
17. A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas.
Díaz Méndez AB; Sacconi A; Tremante E; Lulli V; Caprara V; Rosanò L; Goeman F; Carosi M; Di Giuliani M; Vari G; Silvani A; Pollo B; Garufi C; Ramponi S; Simonetti G; Ciusani E; Mandoj C; Scalera S; Villani V; Po A; Ferretti E; Regazzo G; Rizzo MG
J Exp Clin Cancer Res; 2023 Mar; 42(1):66. PubMed ID: 36932446
[TBL] [Abstract][Full Text] [Related]
18. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of microRNA-107 predicts poorer prognosis in glioma.
Ji Y; Wei Y; Wang J; Ao Q; Gong K; Zuo H
Tumour Biol; 2015 Jun; 36(6):4461-6. PubMed ID: 25596705
[TBL] [Abstract][Full Text] [Related]
20. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
